Radient Technologies Inc RDDTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.02 / $0.02
- Market Cap
- $53,986.80
- Volume/Avg
- 100,700 / 622,471
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 33
- Website
- https://www.radientinc.com
Valuation
|
Metric
|
RDDTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RDDTF
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.09 |
Interest Coverage | −5.04 |
Quick Ratio
RDDTF
Profitability
|
Metric
|
RDDTF
|
|---|---|
Return on Assets (Normalized) | −27.00% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −298.97% |
Return on Assets
RDDTF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Dcmkwypx | Dvjldx | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Mxzvjkjrlz | Gjdt | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ybplvwff | Jpt | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nvlwhgb | Jbgq | $14.7 Bil | |
VTRS
| Viatris Inc | Pmtcnmlx | Tmdt | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Znnykjty | Pskm | $11.9 Bil | |
CTLT
| Catalent Inc | Jrlcwgvk | Sflgx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Cpqkmvk | Vpf | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Zppdpjpg | Dsxh | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pbvgyysd | Ptbpqp | $3.5 Bil |